Xenoport (f/k/a XNPT)

[DAD2]

News From www.stockpickr.com:

XenoPort

XenoPort (XNPT) is a biopharmaceutical company focused on developing and commercializing a portfolio of internally for the treatment of neurological disorders. This stock is trading up 10.2% to $5.70 in recent trading.

Today’s Range: $5.28-$5.63

52-Week Range: $3.46-$7.90

Volume: 502,000

Three-Month Average Volume: 416,331

Shares of XNPT are ripping higher today after Wells Fargo initiated the stock with an outperform rating and a price target of $7 to $9. Analyst Brian Abrahams said, “While the opportunity for marketed agent Horizant and phase III candidate arbaclofen placarbil may be more modest, we believe their combined future revenue streams put a floor in valuation near where the shares currently trade.”